Stigma reduction: an essential ingredient to ending AIDS by 2030

Lancet HIV. 2021 Feb;8(2):e106-e113. doi: 10.1016/S2352-3018(20)30309-X.

Abstract

Ending the AIDS epidemic by 2030 will require addressing stigma more systematically and at a larger scale than current efforts. Existing global evidence shows that stigma is a barrier to achieving each of the 90-90-90 targets; it undermines HIV testing, linkage to care, treatment adherence, and viral load suppression. However, findings from both research studies and programmatic experience have helped to inform the growing body of knowledge regarding how to reduce stigma, leading to key principles for HIV stigma reduction. These principles include immediately addressing actionable drivers of stigma, centring groups affected by stigma at the core of the response, and engaging opinion leaders and building partnerships between affected groups and opinion leaders. Although there is still room to strengthen research on stigma measurement and reduction, in particular for intersectional stigma, the proliferation of evidence over the past several decades on how to measure and address stigma provides a solid foundation for immediate and comprehensive action.

Publication types

  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / diagnosis
  • Acquired Immunodeficiency Syndrome / prevention & control*
  • Acquired Immunodeficiency Syndrome / psychology*
  • Acquired Immunodeficiency Syndrome / virology
  • Anti-HIV Agents / therapeutic use
  • Epidemics / prevention & control*
  • Fear / psychology*
  • Female
  • HIV / drug effects
  • HIV / growth & development
  • HIV / pathogenicity
  • HIV Testing / ethics
  • Humans
  • Male
  • Patient Compliance / psychology
  • Patient Compliance / statistics & numerical data
  • Social Isolation / psychology
  • Social Stigma*
  • Treatment Adherence and Compliance / psychology
  • Treatment Adherence and Compliance / statistics & numerical data
  • Viral Load / drug effects

Substances

  • Anti-HIV Agents